Keyphrases
Pathologic
100%
Mammalian Target of Rapamycin (mTOR)
100%
Type II Endometrial Cancer
100%
Insulin-like Growth Factor 1 Receptor (IGF1R)
60%
Protein Expression
40%
Overall Survival
40%
Human Epidermal Growth Factor Receptor 2 (HER2)
40%
Immunohistochemistry
20%
High-level Expression
20%
Scoring System
20%
Variable Expression
20%
Regulatory Component
20%
Working Diagnosis
20%
Clear Cell
20%
Semi-quantitative Assessment
20%
Hazard Ratio
20%
Kaplan-Meier Estimator
20%
Cox Regression Model
20%
Endometrioid
20%
Recurrent Endometrial Cancer
20%
Papillary Serous
20%
Multivariable Cox Regression
20%
Carcinosarcoma
20%
Carcinosarcoma Uterus
20%
Expression Score
20%
Medicine and Dentistry
Uterine Cancer
100%
Tamoxifen
100%
Mammalian Target of Rapamycin
83%
Overall Survival
33%
Protein Expression
33%
Epidermal Growth Factor Receptor
33%
Vasculotropin
33%
Carcinosarcoma
33%
Clear Cell
16%
Malignant Neoplasm
16%
Kaplan Meier Method
16%
Hazard Ratio
16%
Proportional Hazards Model
16%
Scoring System
16%
Immunohistochemistry
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tamoxifen
100%
Endometrium Cancer
100%
Overall Survival
33%
Vasculotropin
33%
Carcinosarcoma
33%
Epidermal Growth Factor Receptor
33%
Malignant Neoplasm
16%